JP4963547B2 - オキソリン化合物を有効成分とする医薬 - Google Patents
オキソリン化合物を有効成分とする医薬 Download PDFInfo
- Publication number
- JP4963547B2 JP4963547B2 JP2005335445A JP2005335445A JP4963547B2 JP 4963547 B2 JP4963547 B2 JP 4963547B2 JP 2005335445 A JP2005335445 A JP 2005335445A JP 2005335445 A JP2005335445 A JP 2005335445A JP 4963547 B2 JP4963547 B2 JP 4963547B2
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- group
- cells
- oxoline
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- SOFOIPRXOJJTCV-OUKQBFOZSA-N CC(/C=C/P(c1ccccc1)(c1ccccc1)O)=O Chemical compound CC(/C=C/P(c1ccccc1)(c1ccccc1)O)=O SOFOIPRXOJJTCV-OUKQBFOZSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
で表わされるホスフィンオキシド基で置換された芳香族化合物を用いた発光素子(特許文献6参照)、ポリイソプレニルモノホスフェート化合物を活性成分とした制ガン剤(特許文献7参照)などが知られている。
で表わされるオキソリン化合物を有効成分として含有するガン細胞増殖抑制剤を提供するものである。
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005335445A JP4963547B2 (ja) | 2005-11-21 | 2005-11-21 | オキソリン化合物を有効成分とする医薬 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005335445A JP4963547B2 (ja) | 2005-11-21 | 2005-11-21 | オキソリン化合物を有効成分とする医薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007137838A JP2007137838A (ja) | 2007-06-07 |
JP4963547B2 true JP4963547B2 (ja) | 2012-06-27 |
Family
ID=38201148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005335445A Active JP4963547B2 (ja) | 2005-11-21 | 2005-11-21 | オキソリン化合物を有効成分とする医薬 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4963547B2 (ja) |
-
2005
- 2005-11-21 JP JP2005335445A patent/JP4963547B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2007137838A (ja) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2292643T3 (es) | Tratamiento de los efectos colaterales de la estatina. | |
TWI222863B (en) | Synergistic pharmaceutical compositions comprising anthracycline derivatives and anticancer agents | |
AU2002223302A1 (en) | Treatment of statin side effects | |
EP0196415A2 (en) | Trichostatins A and C as antitumour drugs | |
EA018757B1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
KR100861428B1 (ko) | 암 치료용 지방산 유사체 | |
JPH0225415A (ja) | 癌転移抑制剤 | |
CA2286557A1 (en) | Phorbol esters as anti-neoplastic agents | |
WO2002094286A1 (fr) | Inhibiteurs de metastases cancereuses contenant des derives d'acide phosphatidique carbacycliques | |
RU2310445C2 (ru) | Применение гидроксиолеиновой кислоты и родственных соединений при производстве лекарственных средств | |
JP2024023269A (ja) | 抗腫瘍剤及び配合剤 | |
JP4963547B2 (ja) | オキソリン化合物を有効成分とする医薬 | |
JP5553275B2 (ja) | 金属錯体およびこれを有効成分として含有する抗がん剤 | |
CN1302780C (zh) | 烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用 | |
JP4883753B2 (ja) | 医薬 | |
KR101780054B1 (ko) | 2-에톡시프로피온산 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 유방암 예방 또는 치료용 약학적 조성물 | |
Chang et al. | Inositol phospholipid pathway inhibitors and regulators Inositol phospholipid pathway inhibitors and regulators | |
Hussain et al. | Design, synthesis and biological evaluation of new Myo-inositol derivatives as potential RAS inhibitors | |
KR20140035974A (ko) | 종양 질환 치료를 위한 약제 조성물 | |
US20040072915A1 (en) | Novel medicines based on sesquiterpene mixtures | |
US20240109925A1 (en) | Enhanced Anti-Proliferative and Antitumor Immune Effects of Mitochondria-Targeted Hydroxyurea | |
EP1299400B1 (en) | Novel cytotoxic compounds and their use | |
US20230381083A1 (en) | Phytic Acid Ester Derivative | |
US11648217B2 (en) | Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents | |
AU639758B2 (en) | Branched alkyl esters of 4-bis (chloroethyl) aminophenyl-alkyl carboxylic acids for treatment of primary and metastatic tumors of the lymphatic system, and of cancers of the breast and ovaries |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080530 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7421 Effective date: 20090608 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111108 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111216 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120316 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120326 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150406 Year of fee payment: 3 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |